Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Finch Therapeutcs Grp Inc (FNCH)

Finch Therapeutcs Grp Inc (FNCH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Finch Announces Delisting from Nasdaq and SEC Deregistration GlobeNewswire - Mon Oct 21, 2024

FNCH : 7.3000 (-39.17%)
Finch Therapeutics to Participate in Upcoming June Investor Conferences Globe Newswire - Thu Jun 2, 2022

SOMERVILLE, Mass., June 02, 2022 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage...

FNCH : 7.3000 (-39.17%)
Finch Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results Globe Newswire - Mon May 16, 2022

FDA lifted clinical hold on IND for CP101Enrollment in PRISM4 Phase 3 trial of CP101 in recurrent CDI expected to proceed in H2 2022$15 million drawn from...

FNCH : 7.3000 (-39.17%)
Finch Therapeutics to Host Corporate Update Conference Call and Webcast on May 16, 2022 Globe Newswire - Mon May 9, 2022

SOMERVILLE, Mass., May 09, 2022 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage...

FNCH : 7.3000 (-39.17%)
Why Finch Therapeutics Stock Is Skyrocketing Today Motley Fool - Fri Apr 29, 2022

The FDA, at long last, has lifted a clinical hold on Finch's C. diff program.

FNCH : 7.3000 (-39.17%)
Finch Therapeutics Announces Removal of FDA Clinical Hold on CP101 IND Globe Newswire - Thu Apr 28, 2022

SOMERVILLE, Mass., April 28, 2022 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage...

FNCH : 7.3000 (-39.17%)
Finch Therapeutics Announces Workforce Restructuring to Focus Resources on Key Development Programs Globe Newswire - Tue Apr 19, 2022

SOMERVILLE, Mass., April 19, 2022 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage...

FNCH : 7.3000 (-39.17%)

Barchart Exclusives

Aehr Test Systems Soars More Than 15% on ASIC Chip Testing News. Should You Buy AEHR Stock Today? Barchart - 34 minutes ago
Aehr Test Systems stock rallied on a record $41 million production expansion order. But caution is still warranted in playing AEHR shares at current levels. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.